Home
Dashboard
Curated content
Startups & Scaleups
New startups
Job board
Corporates
Investors
Funding rounds
Exits
Accelerators
Workspaces
Universities
More
Matching tool
Investment heatmap
Themes
News
Companies
Synerkine Pharma
Save
Synerkine Pharma
Verified
Synerkine Pharma is a developer of fusion proteins for the treatment of chronic pain
Launch date
2018
Ownership
venture capital
Firm valuation
€14—22m
(Dealroom.co estimates Dec 2021.)
Naarden North Holland (HQ)
https://www.synerkinepharma.com/
B2B
health
biotechnology
biotech and pharma
RELATED LANDSCAPES AND LISTS
Company information
Edit
Launch date
2018
Ownership
venture capital
Firm valuation
€14—22m
(Dealroom.co estimates Dec 2021.)
Synerkine Pharma funding
Synerkine Pharma investors
Edit
Date
Investors
Amount
Round
Mar 2019
Thuja Capital
$3.7m
Series A
Dec 2021
*
Thuja Capital
Utrecht Holdings
Flerie Invest
$3.9m
Series A
Total Funding
€7m
Recent News about Synerkine Pharma
Edit
Tech stack
Group
Tech stack
Learn more about the technologies and tools that this company uses.
LOGIN FOR ACCESS